Mattia Alberto Di Civita | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
PARP inhibitor-based treatment in metastatic, castration-resistant prostate cancer (mCRPC). A systematic review and meta-analysis	BJUI COMPASS	2025
Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2024
Immunotherapy-Based Combinations in First-Line Urothelial Cancer: A Systematic Review and Individual Patient Data (IPD) Meta-Analysis	CURRENT ONCOLOGY	2024
Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1)	TARGETED ONCOLOGY	2024
Real-Life Comparative Analysis of Robotic-Assisted Versus Laparoscopic Radical Prostatectomy in a Single Centre Experience	CANCERS	2024
The management of oligometastatic disease in colorectal cancer: present strategies and future perspectives	CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY	2023
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials	CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY	2023
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets	FRONTIERS IN ONCOLOGY	2023
The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.	EUROPEAN JOURNAL OF CANCER	2021
Reply to the letter entitled: Re: The first report on Covid-19 vaccine refusal by patients with cancer in Italy: Early data from a single-institute survey	EUROPEAN JOURNAL OF CANCER	2021